Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study.
Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification For Atherosclerosis Regression Treatment (JART) Investigators. Nohara R, et al. Among authors: yokoi h. Circ J. 2013;77(6):1526-33. doi: 10.1253/circj.cj-12-1149. Epub 2013 Mar 14. Circ J. 2013. PMID: 23486191 Free article. Clinical Trial.
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.
Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Nohara R, et al. Among authors: yokoi h. Circ J. 2012;76(1):221-9. doi: 10.1253/circj.cj-11-0887. Epub 2011 Nov 16. Circ J. 2012. PMID: 22094911 Free article. Clinical Trial.
Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART study.
Yamazaki T, Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Yamazaki T, et al. Among authors: yokoi h. Int Heart J. 2013;54(1):33-9. doi: 10.1536/ihj.54.33. Int Heart J. 2013. PMID: 23428922 Free article. Clinical Trial.
Can intensive lipid-lowering therapy improve the carotid intima-media thickness in Japanese subjects under primary prevention for cardiovascular disease?: The JART and JART extension subanalysis.
Daida H, Nohara R, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Daida H, et al. Among authors: yokoi h. J Atheroscler Thromb. 2014;21(7):739-54. doi: 10.5551/jat.19109. Epub 2014 Jun 20. J Atheroscler Thromb. 2014. PMID: 24953046 Free article. Clinical Trial.
Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study.
Kurabayashi M, Sakuma I, Kawamori R, Daida H, Yamazaki T, Yoshida M, Hata M, Masuda I, Kaku K, Yokoi H, Kishimoto J, Nohara R. Kurabayashi M, et al. Among authors: yokoi h. J Atheroscler Thromb. 2010 Apr 30;17(4):416-22. doi: 10.5551/jat.2899. Epub 2010 Mar 9. J Atheroscler Thromb. 2010. PMID: 20215710 Free article. Clinical Trial.
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R. Taguchi I, et al. Among authors: yokoi h. Circulation. 2018 May 8;137(19):1997-2009. doi: 10.1161/CIRCULATIONAHA.117.032615. Circulation. 2018. PMID: 29735587 Free PMC article. Clinical Trial.
Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry.
Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T; PACIFIC investigators. Daida H, et al. Among authors: yokoi h. Circ J. 2013;77(4):934-43. doi: 10.1253/circj.cj-13-0174. Epub 2013 Mar 15. Circ J. 2013. PMID: 23502993 Free article. Clinical Trial.
Higher Hemoglobin A1c After Discharge Is an Independent Predictor of Adverse Outcomes in Patients With Acute Coronary Syndrome　- Findings From the PACIFIC Registry.
Noguchi K, Sakakibara M, Asakawa N, Tokuda Y, Kamiya K, Yoshitani T, Oba K, Miyauchi K, Nishizaki Y, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Origasa H, Isshiki T, Morino Y, Daida H, Tsutsui H; PACIFIC investigators. Noguchi K, et al. Among authors: yokoi h. Circ J. 2016 Jun 24;80(7):1607-14. doi: 10.1253/circj.CJ-15-1126. Epub 2016 May 19. Circ J. 2016. PMID: 27194465 Free article. Clinical Trial.
Poor implementation of cardiac rehabilitation despite broad dissemination of coronary interventions for acute myocardial infarction in Japan: a nationwide survey.
Goto Y, Saito M, Iwasaka T, Daida H, Kohzuki M, Ueshima K, Makita S, Adachi H, Yokoi H, Omiya K, Mikouchi H, Yokoyama H; Japanese Cardiac Rehabilitation Survey Investigators. Goto Y, et al. Among authors: yokoi h. Circ J. 2007 Feb;71(2):173-9. doi: 10.1253/circj.71.173. Circ J. 2007. PMID: 17251662 Free article.
967 results